Cardio-oncology without borders

An international professional community bringing together specialists from across Eurasia so that cancer treatment is effective and the cardiovascular health of patients is protected.

RussiaKazakhstanUzbekistanTajikistanKyrgyzstanRussiaKazakhstanUzbekistanTajikistanKyrgyzstanRussiaKazakhstanUzbekistanTajikistanKyrgyzstanRussiaKazakhstanUzbekistanTajikistanKyrgyzstan
2025
year the association was founded
7
leading specialists among the founders
5
countries represented at the founding
2026
first congress of the association: 18–19 September, Astana

Upcoming events

Congresses, schools, webinars and round tables for specialists across disciplines and countries.

About the association

We bring cardiologists and oncologists together so that modern cancer treatment is as effective, and as safe for the heart, as possible.

The Eurasian Cardio-Oncology Association is an international, multidisciplinary professional community founded on 1 May 2025 in Tashkent by leading specialists from Russia, Kazakhstan, Uzbekistan, Tajikistan and Kyrgyzstan.

The association unites cardiologists, oncologists, haematologists, imaging specialists, clinical pharmacologists, researchers and healthcare leaders. Our purpose is to advance cardio-oncology across Eurasia and to establish shared approaches to risk assessment, prevention, early diagnosis and treatment of the cardiovascular complications of anticancer therapy.

We create a space for research collaboration, professional education and the exchange of clinical experience, support early-career specialists and help build dedicated cardio-oncology services. At the centre of our work is the patient, who needs effective cancer treatment and reliable protection of the cardiovascular system at the same time.

Founded on 1 May 2025 in Tashkent
Founders represent five countries of Eurasia
First congress on 18–19 September 2026 in Astana
Collaboration between cardiologists, oncologists and allied specialists
Research and education projects built for everyday clinical care
Key topics
  • Prevention and early diagnosis of cardiotoxicity
  • Heart failure and cardio-renal-metabolic risk
  • Biomarkers, imaging and digital technologies
  • Thrombosis, vascular toxicity and arrhythmias
  • Follow-up, rehabilitation and quality of life after cancer treatment

Focus areas

From research and guidelines to education, clinical practice and international partnership.

About the association

Research and guidelines

01

We build the scientific foundation of cardio-oncology care and support the adoption of evidence-based approaches.

  • Multicentre studies
  • Consensus statements and algorithms
  • Registries and data analysis

Education

02

We help specialists master current methods of prevention, diagnosis and treatment.

  • Congresses and conferences
  • Webinars and schools
  • Materials for continuing education

Clinical practice

03

We support multidisciplinary care pathways and the creation of dedicated cardio-oncology services.

  • Models for cardio-oncology centres
  • Clinical checklists
  • Consultations and exchange of experience

International partnership

04

We connect the professional communities of Eurasia and build collaboration with international experts.

  • Joint research projects
  • Expert meetings
  • Knowledge exchange and early-career initiatives
Why it matters

Cancer and cardiovascular disease call for a single strategy to save lives

20.6 million

new cancer cases worldwide every year.

Source: IARC, 2026
19.8 million

deaths from cardiovascular disease in 2022 — around 32% of all deaths.

Source: WHO, 2025
≈35 million

new cancer cases a year projected by 2050.

Source: IARC, 2026